Navigation Links
'Know Your L-Dex(TM)' (Lymphedema Index) Awareness Campaign Attracts Large Numbers of Breast Cancer Survivors at Komen Race for the Cure(R) Events
Date:10/30/2008

Breast Cancer Survivors Learn about the Importance of Early Lymphedema Detection and Intervention with L-Dex Readings

SAN DIEGO, Oct. 30 /PRNewswire/ -- A large number of breast cancer survivors received complimentary L-Dex readings as part of the "Know Your L-Dex" awareness campaign activities at recent Komen Race for the Cure(R) events in Houston and Dallas.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081030/NY43020 )

Dr. Walton Taylor, a breast surgeon at the Medical City Dallas Hospital, provided survivors with complimentary readings using an FDA-cleared L-Dex medical device developed by ImpediMed Ltd. (ASX: IPD).

L-Dex readings serve as an aid for medical professionals to clinically assess female breast cancer patients for the early signs of unilateral lymphedema of the arm (swelling that occurs in one arm following breast cancer treatment), potentially before symptoms such as heaviness or visible swelling are present.

"Lymphedema is one of the major concerns of many breast cancer survivors, and it is important that they are educated on the importance of early detection and intervention," said Dr. Taylor. "With the help of ImpediMed's L-Dex devices, medical professionals can now perform pre-operative baseline assessments and conduct ongoing surveillance for the early signs of lymphedema in patients."

"The outcomes of the 'Know Your L-Dex' activities in Texas greatly exceeded our expectations," said Greg Brown, CEO of ImpediMed. "In addition to performing the readings, Dr. Taylor answered survivors' questions about lymphedema and helped Komen Race for the Cure(R) participants to gain a better understanding of the importance of early lymphedema detection and intervention. We look forward to bringing the 'Know Your L-Dex' activities to other markets this quarter and throughout next year."

Additional "Know Your L-Dex" activities are scheduled for November at the Komen San Diego Race for the Cure(R) and the Breast Cancer Network of Strength's Life in Balance: Breast Cancer Survivorship Forum in Chicago.

For additional information about L-Dex or the "Know Your L-Dex" campaign, call 858-412-0199 x1235 or visit http://www.l-dex.com.

About Lymphedema

Lymphedema is a condition that can cause significant swelling of the upper and lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is responsible for draining excess fluid from the body and is a key component of the immune system, is damaged or altered. In breast cancer patients, this can occur after surgery, such as removal or biopsy of the lymph nodes, and/or radiation therapy. It is estimated that six percent to 40 percent of patients with breast cancer develop lymphedema, and that it often occurs within the first two years after surgery. For some cancer survivors and others at risk, a low level lymphedema can occur 10 years to 15 years following the initial primary treatment and develop into a condition that has a serious impact on overall health and quality of life.

About ImpediMed

ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedence Spectroscopy (BIS) technologies to aid medical providers in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed's primary product range consists of a number of medical devices that enable surgeons, oncologists, therapists and radiation oncologists to clinically assess patients for the potential onset of secondary lymphedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may help prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed has the first medical device with an FDA clearance in the United States to aid health care professionals clinically assess secondary lymphedema of the arm in female breast cancer patients. For more information, visit http://www.impedimed.com.

Note: ImpediMed's device is not intended to diagnose or predict lymphedema of an extremity.

Media Contacts: Wendy Lau or Bianca Molina

Russo Partners

(212) 845-4272 office

wendy.lau@russopartnersllc.com

bianca.molina@russopartnersllc.com


'/>"/>
SOURCE ImpediMed Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. What Boomers Need to Know About Digestion; Enzymatic Therapy's CompleteGest1 Renew targets special digestive issues
2. Cholesterol-lowering drugs may also lower PSA, but whether they cut cancer risk is still not known
3. Top 10 Things Pharma Should Know About India - Free Paper From Decision Resources
4. Frost & Sullivan Acknowledges Syntec Optics Unwavering Focus on Innovation and Strategies to Improve Profitability
5. The Public Knows the Candidates Views on Healthcare Reform, But Do the Candidates Know What Healthcare Professionals Think?
6. Little-Known Fat Can Be a Heartbreaker
7. Pennsylvania Health Department Offers Measures to Reduce Spread of Drug-Resistant Staph Known as MRSA
8. Many Doctors Dont Know Blood Pressure Guidelines
9. Even Kids With Known Allergies Can Be Safely Vaccinated
10. What You Need to Know About Womens Oral Health
11. During the Recent Chino Based Earthquake Did You Know What to Do? The City of Burbank Senior Services Division and the National Alliance For Healthy Communities Would Like to Help.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: